FDA Enforcement Class II Completed

A1CNow+ Multi-Test HbA1c System consists of (1) a semi-disposable plastic-encased device (the monitor), (2) a plastic cartridge enclosing dry reagent strips, and (3) a sample dilution kit for: collecting the blood sample, mixing the sample with the required pre-treatment solution, and delivering the sample to the cartridge.

Recall: Z-0223-2025 · Reported October 30, 2024

Enforcement

Recall Number
Z-0223-2025
Event ID
95416
Classification
Class II
Status
Completed
Product Type
Devices
Firm
Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
October 30, 2024
Initiation Date
September 18, 2024
Classification Date
October 24, 2024
Address
4600 Anson Blvd, N/A, Whitestown, IN, 46075-4489, United States

Description

A1CNow+ Multi-Test HbA1c System consists of (1) a semi-disposable plastic-encased device (the monitor), (2) a plastic cartridge enclosing dry reagent strips, and (3) a sample dilution kit for: collecting the blood sample, mixing the sample with the required pre-treatment solution, and delivering the sample to the cartridge.

Reason

The reason for this recall is PTS Diagnostics, Inc. received complaints of non-matching cartridge and analyzer codes within the product test system box. Use of cartridges and analyzers with non-matching codes may result in inaccurate test results as components within each lot number are meant to be used together, and not mixed between lots. Therefore, the test results may possibly lead to Hemoglobin A1C positive or negative bias results. While the product is for monitoring only, over recovery with a higher than accurate value can be an indication for increased therapy; such as physical activity, weight reduction, meal management, pharmaceutical therapy.

Code Info

UDI-DI: 00381933021011 Lot Numbers: 9331803, 2323019

Distribution

Worldwide distribution - US Nationwide and the countries of Japan, South Africa.

Quantity

2,452 units